How Research Partnership supported the development of a robust and reliable index tracking program in the multiple myeloma space
Research Partnership, an Inizio Advisory company, worked with their client to develop a trackable index for patients newly diagnosed with multiple myeloma to track and measure the patient experience, including unmet needs, access barriers and burden of the disease at various stages.
Read more about the client’s challenge, Research Partnership’s solution and the outcomes.
Discover more about how we help to shape the future of oncology treatments here.
Jump to a slide with the slide dots.
How can scalable AI training elevate MSL performance in real-time?
Discover how AI-powered training transforms MSL performance by delivering real-world practice and confidence for HCP engagement.
Read moreHow can digital insights drive smarter engagement with hematologic oncologists?
Narratev™ allows you to understand how hematologic oncologists engage with digital content, optimizing channel strategy and investment.
Read moreHow can you simplify science and accelerate impact with AI-powered Plain Language Summaries (PLS) at scale?
iON AI PLS enables you to deliver compliant, patient-friendly Plain Language Summaries faster, without compromising accuracy.
Read more